Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.96 USD | -0.50% | -0.33% | -12.80% |
05-20 | Exelixis Settles Cabometyx Patent Litigation with Cipla | MT |
05-14 | Transcript : Exelixis, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 02:35 PM |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.80% | 6.13B | |
+7.61% | 115B | |
+12.72% | 107B | |
-13.44% | 22.31B | |
-3.99% | 21.6B | |
-6.59% | 18.23B | |
-39.93% | 17.62B | |
+6.79% | 14.26B | |
+32.92% | 12.37B | |
-27.78% | 8.28B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Transcript : Exelixis, Inc., Q1 2024 Earnings Call, Apr 30, 2024